Skip to main content

Nonprofit · EIN 47-3355381

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

Tax-exempt · SAN FRANCISCO, CA 94129

Financials

$23.7M$42.9M2023$66.9M$54.5M2024$180.1M$53.8M2025
Revenue Expenses · by fiscal year end
Financials of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$180,131,815$53,795,577$126,336,238$285,156,429$8,671,312$276,485,117
December 31, 2024990$66,947,169$54,471,034$12,476,135$223,870,654$38,432,216$185,438,438
December 31, 2023990$23,662,636$42,903,351-$19,240,715$255,027,743$52,813,770$202,213,973
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$175,140,008
Program service revenue
$1,240,750
Investment income
$3,466,352
Royalties
$284,705
Net gain from sales of assets
$1,042
Other revenue
$284,705

Expenses

Grants and similar amounts paid
$3,623,255
Compensation of officers, directors and key employees
$2,707,897
Other salaries and wages
$6,961,962
Salaries, compensation and benefits (total)
$11,188,563
Professional fundraising fees
$0
Legal fees
$3,245,104
Accounting fees
$379,762
Occupancy
$1,617,210
Travel
$804,068
Program services (functional)
$46,776,153
Management and general (functional)
$6,552,383
Fundraising (functional)
$467,041

Balance sheet and other

Total assets, start of year
$223,870,654
Total assets, end of year
$285,156,429
Total liabilities, end of year
$8,671,312
Net assets, end of year
$276,485,117
Net assets without donor restrictions
$243,998,841
Net assets with donor restrictions
$32,486,276
Gross receipts
$180,131,815
Employees
31
Volunteers
20
Year formed
2015
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
TARAK MODYCHIEF BUSINESS OFF. THRU 8/25
Highest-paid employee
40$791,771$94,692
JOHN CONNOLLY PHDCHIEF SCIENTIFIC OFFICER
Key employee
40$703,149$75,026
KAREN E KNUDSEN COSTELLOCEO AS OF 03/2025
Trustee or director, Officer
40$655,478$58,978
KEVIN MARKSCHIEF LEGAL OFFICER
Key employee
40$623,269$75,194
CHRIS CABANSKI THRU 1225SR DIR, NETWORK CLIN. RESEARCH
Highest-paid employee
40$314,624$200,315
SARA COBLINSR VP FINANCE & ADMIN.
Key employee
40$444,632$51,918
SHANE CORCORANSENIOR VP, STRAT. OPS. & COMMS
Highest-paid employee
40$441,686$32,245
MARKO SPASICSR MEDICAL DIR, HEAD OF MED
Highest-paid employee
40$398,778$21,808
CHRISTEN DIPETRILLOHEAD OF INTELLECTUAL PROPERTY
Highest-paid employee
40$330,222$74,541
SEAN N PARKERCHAIR OF THE BOARD & DIRECTOR
Trustee or director, Officer
5$0$0
MICHAEL POLANSKYEXECUTIVE VP & DIRECTOR
Trustee or director, Officer
5$0$0
TOM VAN LOBEN SELSTREASURER & DIRECTOR
Trustee or director, Officer
1$0$0
JEFFREY A BLUESTONE PHDVICE CHAIR & DIRECTOR
Trustee or director
1$0$0
TONY COLES MDDIRECTOR THRU 10/25
Trustee or director
0.8$0$0
ERIC ESRAILIAN MD MPHDIRECTOR
Trustee or director
1$0$0
11 more people on this return
NameTitleHours / weekCompensation
SCOTT GOTTLIEB MDDIRECTOR
Trustee or director
1$0
BEN HOROWITZDIRECTOR
Trustee or director
1$0
JEFF HUBERDIRECTOR
Trustee or director
1$0
BOB HUGINDIRECTOR
Trustee or director
1$0
REED JOBSDIRECTOR
Trustee or director
1$0
BOB NELSENDIRECTOR
Trustee or director
1$0
BRUCE PARKER PHDDIRECTOR
Trustee or director
1$0
BOB PITTMANDIRECTOR
Trustee or director
1$0
RAMY IBRAHIM MDDIRECTOR THRU 10/25
Trustee or director
0.8$0
MARGO GEORGIADISDIRECTOR
Trustee or director
1$0
SUSAN DAWSONSECRETARY
Officer
5$0
990 for the year ended December 31, 2024: 25 people
NameTitleHours / weekCompensationOther / benefits
JOHN CONNOLLY PHDCHIEF SCIENTIFIC OFFICER
Key employee
40$855,710$71,836
KEVIN MARKSCHIEF LEGAL OFFICER
Key employee
40$840,863$72,056
UTE DUGAN MDCHIEF MED. OFFICER THRU 6/24
Highest-paid employee
20$715,023$105,296
TARAK MODYCHIEF BUSINESS OFFICER
Highest-paid employee
40$632,310$71,836
SHANE CORCORANSENIOR VP, STRAT. OPS. & COMMS
Highest-paid employee
40$669,429$30,971
SARA COBLINSR VP FINANCE & ADMIN.
Key employee
40$564,812$49,885
MARKO SPASICSR MEDICAL DIR, HEAD OF MED
Highest-paid employee
40$418,090$9,159
CHRISTEN DIPETRILLOHEAD OF INTELLECTUAL PROPERTY
Highest-paid employee
40$354,287$72,064
SEAN N PARKERCHAIR OF THE BOARD & DIRECTOR
Trustee or director, Officer
5$0$0
MICHAEL POLANSKYEXECUTIVE VP & DIRECTOR
Trustee or director, Officer
5$0$0
TOM VAN LOBEN SELSTREASURER & DIRECTOR
Trustee or director, Officer
1$0$0
JEFFREY A BLUESTONE PHDVICE CHAIR & DIRECTOR
Trustee or director
1$0$0
TONY COLES MDDIRECTOR
Trustee or director
1$0$0
ERIC ESRAILIAN MD MPHDIRECTOR
Trustee or director
1$0$0
SCOTT GOTTLIEB MDDIRECTOR
Trustee or director
1$0$0
BEN HOROWITZDIRECTOR
Trustee or director
1$0$0
JEFF HUBERDIRECTOR
Trustee or director
1$0$0
BOB HUGINDIRECTOR
Trustee or director
1$0$0
REED JOBSDIRECTOR
Trustee or director
1$0$0
BOB NELSENDIRECTOR
Trustee or director
1$0$0
BRUCE PARKER PHDDIRECTOR
Trustee or director
1$0$0
BOB PITTMANDIRECTOR
Trustee or director
1$0$0
RAMY IBRAHIM MDDIRECTOR
Trustee or director
1$0$0
MARGO GEORGIADISDIRECTOR
Trustee or director
1$0$0
SUSAN DAWSONSECRETARY
Officer
5$0$0
990 for the year ended December 31, 2023: 26 people
NameTitleHours / weekCompensationOther / benefits
UTE DUGAN MDCHIEF MEDICAL OFFICER
Key employee
40$789,156$55,067
JOHN CONNOLLY PHDCHIEF SCIENTIFIC OFFICER
Key employee
40$763,765$53,749
KEVIN MARKSCHIEF LEGAL OFFICER
Highest-paid employee
40$559,373$114,899
TARAK MODYCHIEF BUSINESS OFFICER
Highest-paid employee
40$614,960$54,899
SHANE CORCORANSENIOR VP, STRAT. OPS. & COMMS
Highest-paid employee
40$547,440$41,286
SARA COBLINSR VP FINANCE & ADMIN.
Key employee
40$548,044$38,646
MARKO SPASICSR MEDICAL DIR, HEAD OF MED
Highest-paid employee
40$476,280$15,180
CHRIS CABANSKISR DIR, NETWORK CLINICAL RES.
Highest-paid employee
40$355,867$41,334
SEAN N PARKERCHAIR OF THE BOARD & DIRECTOR
Trustee or director, Officer
5$0$0
MICHAEL POLANSKYEXECUTIVE VP & DIRECTOR
Trustee or director, Officer
5$0$0
TOM VAN LOBEN SELSTREASURER & DIRECTOR
Trustee or director, Officer
1$0$0
JEFFREY A BLUESTONE PHDVICE CHAIR & DIRECTOR
Trustee or director
1$0$0
TONY COLES MDDIRECTOR
Trustee or director
1$0$0
ERIC ESRAILIAN MD MPHDIRECTOR
Trustee or director
1$0$0
SCOTT GOTTLIEB MDDIRECTOR
Trustee or director
1$0$0
BEN HOROWITZDIRECTOR
Trustee or director
1$0$0
JEFF HUBERDIRECTOR
Trustee or director
1$0$0
BOB HUGINDIRECTOR
Trustee or director
1$0$0
REED JOBSDIRECTOR
Trustee or director
1$0$0
JOEL MARCUSDIRECTOR THRU 3/23
Trustee or director
0.25$0$0
BOB NELSENDIRECTOR
Trustee or director
1$0$0
BRUCE PARKER PHDDIRECTOR
Trustee or director
1$0$0
BOB PITTMANDIRECTOR
Trustee or director
1$0$0
RAMY IBRAHIM MDDIRECTOR
Trustee or director
1$0$0
MARGO GEORGIADISDIRECTOR
Trustee or director
1$0$0
SUSAN DAWSONSECRETARY
Officer
5$0$0

Address and contacts

Address (IRS master file)
1 LETTERMAN DR STE D3500, SAN FRANCISCO, CA 94129-1504
In care of
% SARA COBLIN
Principal officer (990 for 2025)
SEAN PARKER, 1 LETTERMAN DRIVE D3500, SAN FRANCISCO, CA 94129
Signed the 990
KAREN E KNUDSEN COSTELLO, CEO
Phone
(415) 930-4386
Return prepared by
PwC US Tax LLP

California records

California keeps its own records of charities and corporations. Search them by EIN 47-3355381 or by the name PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO DEVELOP AND ACCELERATE ACCESS TO BREAKTHROUGH CANCER THERAPIES, CURATING INNOVATION FROM DISCOVERY TO PATIENT ACCESS.

990 for the year ended December 31, 2025

Program accomplishments

  • PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI PARTNERS WITH ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS TO CONDUCT ITS DISCOVERY AND CLINICAL RESEARCH AND PROVIDES ITS PARTNERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.
    Expenses $46,776,153 · grants $3,623,255 · revenue $1,240,750

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
47-3355381
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Hospital or medical research organization
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2015
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E12)
Assets (IRS master file)
$285,156,429
Income (IRS master file)
$180,131,815

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$180,131,815$53,795,577$285,156,429XML
990-TDecember 2025–––IRS
990December 2024$66,947,169$54,471,034$223,870,654XML
990-TDecember 2024–––IRS
990December 2023$23,662,636$42,903,351$255,027,743XML
990-TDecember 2023–––IRS
990December 2022$32,769,137$62,241,652$307,154,607IRS
990-TDecember 2022–––IRS
990December 2021–––IRS
990-TDecember 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 47-3355381).

Questions about PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

What is the EIN of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY?
The employer identification number (EIN) of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY is 47-3355381.
Is PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2015.
Are donations to PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY?
The 990 for the year ended December 31, 2025 names SEAN PARKER.
Who are the officers and directors of PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY?
The 990 for the year ended December 31, 2025 lists 26 people; 9 received compensation from the organization, the highest $791,771 (TARAK MODY, CHIEF BUSINESS OFF. THRU 8/25).
How much revenue does PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY have?
On its 990 for the year ended December 31, 2025 it reported revenue of $180,131,815, expenses of $53,795,577 and total assets of $285,156,429 at year end.

Other nonprofits in SAN FRANCISCO

All nonprofits in SAN FRANCISCO · California · Health care